MARKETS

BSE Prices delayed by 5 minutes... Prices as on Feb 21, 2018 - 3:59PM   ABB India 1510.5 [ -0.18% ]ACC 1646.1 [ 0.31% ]Ambuja Cements Ltd. 261.65 [ -0.55% ]Asian Paints Ltd. 1125.55 [ -0.10% ]Axis Bank Ltd. 535.2 [ 0.66% ]Bajaj Auto Ltd. 3020 [ -0.97% ]Bank of Baroda 145.6 [ 0.59% ]Bharti Airtel 419.35 [ 0.41% ]Bharat Heavy Ele 91.65 [ -1.61% ]Bharat Petroleum 447.45 [ -1.41% ]Britannia Ind. 4772.2 [ 0.75% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 596.85 [ -0.84% ]Coal India Ltd. 310.9 [ 0.21% ]Colgate Palm. 1079.25 [ 1.02% ]Dabur India 334.2 [ -1.89% ]DLF Ltd. 220.9 [ -1.67% ]Dr. Reddy's Labs 2168.8 [ 0.31% ]GAIL (India) Ltd. 463.5 [ -0.44% ]Grasim Inds. 1108.6 [ -0.96% ]HCL Technologies 940.6 [ 3.88% ]HDFC 1824.1 [ 0.83% ]HDFC Bank 1855.5 [ -0.44% ]Hero MotoCorp 3490 [ 0.18% ]Hindustan Unilever L 1330.4 [ -0.27% ]Hindalco Indus. 240.65 [ -3.18% ]ICICI Bank 319.3 [ 0.52% ]IDFC L 52.2 [ -0.48% ]Indian Hotels Co 132.4 [ -2.29% ]IndusInd Bank 1596.65 [ -1.93% ]Infosys 1148.7 [ 1.23% ]ITC Ltd. 268.05 [ 2.00% ]Jindal St & Pwr 247.15 [ -1.81% ]Kotak Mahindra Bank 1054.75 [ 0.93% ]L&T 1283.15 [ -0.57% ]Lupin Ltd. 812.9 [ -0.36% ]Mahi. & Mahi 708.45 [ -0.08% ]Maruti Suzuki India 8779.8 [ 0.63% ]MTNL 22.5 [ -0.66% ]Nestle India 7580 [ 0.33% ]NIIT Ltd. 92.8 [ -1.01% ]NMDC Ltd. 129 [ -1.30% ]NTPC 162.25 [ -0.92% ]ONGC 190.1 [ 1.66% ]Punj. NationlBak 117.1 [ 0.47% ]Power Grid Corpo 194.6 [ -0.23% ]Reliance Inds. 928.35 [ 0.97% ]SBI 273.1 [ 1.28% ]Vedanta 327.5 [ -0.23% ]Shipping Corpn. 74.8 [ -2.73% ]Sun Pharma. 524.75 [ -6.19% ]Tata Chemicals 701.15 [ -0.64% ]Tata Global Beverage 268 [ 1.92% ]Tata Motors Ltd. 364.35 [ -1.23% ]Tata Steel 640.55 [ -1.57% ]Tata Power Co. 86.05 [ -0.23% ]Tata Consultancy 3043.05 [ 3.33% ]Tech Mahindra Ltd. 594.4 [ 3.73% ]UltraTech Cement 4139 [ 0.16% ]United Spirits 3172.85 [ -1.31% ]Wipro Ltd 292.25 [ 0.31% ]Zee Entertainment En 574 [ 0.58% ]

News Details

You can view in detail.
Lupin receives USFDA nod for generic Vibra-Tabs tablets 11/09/2017 14:40

Pharma major, Lupin Ltd said that it has received approval from the US health regulator for generic version of Vibra-Tabs.

"...has received final approval for its Doxycycline Hyclate tablet USP, 100 mg from the United States Food and Drug Administration (FDA) to market in the US," the pharma major said in its filing.

Doxycycline Hyclate tablet is the AB rated generic equivalent of Pfizer Inc's Vibra-Tabs, 100 mg.

The drug is indicated in the treatment of infections caused by various microorganisms and as an adjunctive therapy in severe acne.

The company said Doxycycline Hyclate tablet had US sales of USD 149.9 million (in last 12 months ending June 2017) as per IMS MAT June 2017.

Meanwhile, shares of the company were trading at Rs 977.4 apiece, up 0.96 per cent from the previous close at 14:45 hours on BSE.

LOAD MORE